检索结果 - Sheng-Bin Peng

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p

    LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p 由 Mingming Dong, Sheng‐Bin Peng, Yan-hua Yuan, Hongqin Luo

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma

    Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma 由 Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, Shawn T. Estrem, Shuyu Li, Xueqian Gong, Sean G. Buchanan, James R. Henry, James J. Starling, Sheng-Bin Peng

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation

    The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation 由 Vipin Yadav, Teresa F. Burke, Lysiane Huber, Robert D. Van Horn, Youyan Zhang, Sean G. Buchanan, Edward M. Chan, James J. Starling, Richard P. Beckmann, Sheng-Bin Peng

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models

    A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models 由 Genshi Zhao, Weiying Li, Daohong Chen, James R. Henry, Hongyu Li, Zhaogen Chen, Mohammad Zia‐Ebrahimi, Laura J. Bloem, Yan Zhai, Karen Huss, Sheng‐Bin Peng, Denis McCann

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies

    Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies 由 Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul, Lisa Kays, Ming Ye, Peter Vaillancourt, Michele Dowless, Louis F. Stancato, Julie Stewart, Mark Uhlik, Haiyan Long, Shaoyou Chu, Victor H. Obungu

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

    LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer 由 Eliza Vakana, Susan E. Pratt, Wayne Blosser, Michele Dowless, Nicholas Simpson, Xiu‐Juan Yuan, Susan Jaken, Jason R. Manro, Jennifer R. Stephens, Youyan Zhang, Lysiane Huber, Sheng-Bin Peng, Louis F. Stancato

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors

    Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors 由 Mark H. O’Hara, Wells A. Messersmith, Hedy L. Kindler, Wei Zhang, Celine Pitou, Anna M. Szpurka, Dan Wang, Sheng-Bin Peng, Burkhard Vangerow, Anis A. Khan, Mythili Koneru, Andrea Wang‐Gillam

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

    Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models 由 Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul, Lisa Kays, Wendy H. Gough, Julie Stewart, Mark Uhlik, Qi Chen, Yu‐Hua Hui, Maciej J. Zamek‐Gliszczynski, John A. Wijsman, Kelly M. Credille, Liang Yan

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy

    Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy 由 Byung-Sik Cho, Zhihong Zeng, Hong Mu, Zhiqiang Wang, Sergej Konoplev, Teresa McQueen, Marina Protopopova, Jorge E. Cortés, Joseph R. Marszalek, Sheng‐Bin Peng, Wencai Ma, R. Eric Davis, Donald Thornton, Michael Andreeff, Marina Konopleva

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

    Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120 由 Shih-Hsun Chen, Youyan Zhang, Robert D. Van Horn, Tinggui Yin, Sean G. Buchanan, Vipin Yadav, Igor Mochalkin, Swee Seong Wong, Yong Yue, Lysiane Huber, Ilaria Conti, James R. Henry, James J. Starling, Gregory D. Plowman, Sheng-Bin Peng

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

    Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets 由 Ying Chen, Jeremy McGee, Xian‐Ming Chen, Thompson N. Doman, Xueqian Gong, Youyan Zhang, Nicole Hamm, Xiwen Ma, Richard E. Higgs, Shripad V. Bhagwat, Sean G. Buchanan, Sheng-Bin Peng, Kirk A. Staschke, Vipin Yadav, Yong Yue, Hosein Kouros‐Mehr

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I

    Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I 由 Palaniappan Kulanthaivel, A J Kreuzman, Mark A. Strege, Matthew D. Belvo, Tim A. Smitka, Matthew Clemens, James R. Swartling, Kristina L. Minton, Feng Zheng, Eddie L. Angleton, DEBORAH L. MULLEN, Louis N. Jungheim, Valentine J. Klimkowski, Thalia I. Nicas, R. C. Thompson, Sheng-Bin Peng

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <i>BRAF</i> or <i>KRAS</i> Mutations

    Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <i>BRAF</i> or <i>KRAS</i> Mutations 由 Yung-Mae Yao, Gregory P. Donoho, Philip W. Iversen, Youyan Zhang, Robert D. Van Horn, Amélie Forest, Ruslan D. Novosiadly, Yue Webster, Philip J. Ebert, Steven M. Bray, Jason C. Ting, Amit Aggarwal, James R. Henry, Ramón V. Tiu, Gregory D. Plowman, Sheng‐Bin Peng

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

    A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer 由 Ryan J. Sullivan, Antoine Hollebecque, Keith T. Flaherty, Geoffrey I. Shapiro, Jordi Rodón, Michael Millward, Wei Zhang, Ling Gao, Amanda K. Sykes, Melinda D. Willard, Danni Yu, Andrew E. Schade, KrisAnne Crowe, Daniel L. Flynn, Michael D. Kaufman, James R. Henry, Sheng-Bin Peng, Karim A. Benhadji, Ilaria Conti, Michael S. Gordon, Ramón V. Tiu, David S. Hong

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

    ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine 由 Shripad V. Bhagwat, William T. McMillen, Shufen Cai, Baohui Zhao, Matthew Whitesell, Weihua Shen, Lisa Kindler, Robert S. Flack, Wenjuan Wu, Bryan D. Anderson, Yan Zhai, Xiu‐Juan Yuan, Meghann Pogue, Robert D. Van Horn, Xi Rao, Denis McCann, Andrew J. Dropsey, Jason R. Manro, Jennie Walgren, Eunice Yuen, Michael Rodriguez, Gregory D. Plowman, Ramón V. Tiu, Sajan Joseph, Sheng-Bin Peng

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

    Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers 由 Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George, Antje Schaefer, Bjoern Papke, Kathleen Klotz‐Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S.K. Gilbert, Kevin Lin, Onur Dağliyan, Krister Wennerberg, Emanuel F. Petricoin, Nhan L. Tran, Shripad V. Bhagwat, Ramón V. Tiu, Sheng-Bin Peng, Laura E. Herring, Lee M. Graves, Christine Sers, Kris C. Wood, Adrienne D. Cox, Channing J. Der

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

    Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers 由 Sheng-Bin Peng, James R. Henry, Michael D. Kaufman, Wei-Ping Lu, Bryan D. Smith, Subha Vogeti, Thomas J. Rutkoski, Scott Wise, Lawrence Chun, Youyan Zhang, Robert D. Van Horn, Tinggui Yin, Xiaoyi Zhang, Vipin Yadav, Shih-Hsun Chen, Xueqian Gong, Xiwen Ma, Yue Webster, Sean G. Buchanan, Igor Mochalkin, Lysiane Huber, Lisa Kays, Gregory P. Donoho, Jennie Walgren, Denis McCann, Phenil J. Patel, Ilaria Conti, Gregory D. Plowman, James J. Starling, Daniel L. Flynn

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-<i>d</i>]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against <i>BRAF</i> or <i>RAS</i> Mutant Tumor Cells

    Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-<i>d</i>]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Pa... 由 James R. Henry, Michael D. Kaufman, Sheng-Bin Peng, Yu Mi Ahn, Timothy M. Caldwell, Lakshminarayana Vogeti, Hanumaiah Telikepalli, Wei-Ping Lu, Molly M. Hood, Thomas J. Rutkoski, Bryan D. Smith, Subha Vogeti, David F. Miller, Scott Wise, Lawrence Chun, Xiaoyi Zhang, Youyan Zhang, Lisa Kays, Philip A. Hipskind, A.D. Wrobleski, Karen L. Lobb, Julia M. Clay, Jeffrey Cohen, Jennie Walgren, Denis McCann, Phenil J. Patel, David K. Clawson, Sherry Guo, Danalyn Manglicmot, C. Groshong, Cheyenne Logan, James J. Starling, Daniel L. Flynn

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: